Protective effect of new beta2-agonist: 1-(3-bromo-5-isoxazolyl)-2-(tert-butylamino)ethanol hydrochloride, (broxaterol hydrochloride) in bronchial constriction from inhaled distilled water mist | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

2736583

Reference Type

Journal Article

Title

Protective effect of new beta2-agonist: 1-(3-bromo-5-isoxazolyl)-2-(tert-butylamino)ethanol hydrochloride, (broxaterol hydrochloride) in bronchial constriction from inhaled distilled water mist

Author(s)

Robuschi, M; Damonte, C; Fasano, W; Bianco, S; Pasargiklian, M

Year

1985

Is Peer Reviewed?

Yes

Journal

Current Therapeutic Research
ISSN: 0011-393X

Report Number

IPA/85/646065

Volume

Ther

Issue

REF 12

Page Numbers

333-341

Language

English

Abstract

IPA COPYRIGHT: ASHP Oral single doses of 0.25 mg and 0.50 mg Z-1170 HCl (broxaterol hydrochloride) were evaluated in 12 patients with bronchial asthma, aged 16-60 yr, to assess if the drug can inhibit bronchial constriction from inhaled distilled water mist. Drug inhibited bronchial constriction resulted from the bronchogenic stimulus used. The bronchodilating effect appeared to be dose-related.